Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
boston blog main
boston top stories
crispr
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alphabet
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
broad institute of harvard and mit
brook byers
ceo
charles chu
clinical hold
clinical study
combination
commissioner
congress
crispr cas14
crispr-cas9
deals
decheng capital
delisting
democrats
departure
detroit blog main
detroit top stories
diagnostic
drug pricing
What
big
3
×
crispr
3
×
bio
cas
medicine
account
available
based
biosciences
bomb
bosley's
bosley’s
bridge
bucks
business
ceo
cheaper
cracking
crime
departure
develop
diagnostics
editas
exit
expects
explosive
faster
guiding
katrine
mammoth
moves
nuclear
personnel
politics
potential
roundup
rt
set
surprising
things
Language
unset
Current search:
big
×
crispr
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@pmarca
8 years ago
RT @paul1kirby: Cracking account of CRISPR & the explosive potential for medicine, politics & business. "As big as the nuclear bomb" http://www.newyorker.com/magazine/2015/11/16/the-gene-hackers